|
HeMemics Biotechnologies , Inc. (HBI) is a product development and manufacturing company that provides in-vitro reagents to the health care and pharma industries
HBI HeMeDri™ technology can provide desiccated proteins, cells and thin tissues (biologics), in dried or semi-dried format, for ease of transportation and storage. The biologics are maintained and preserved in the desiccated state and functions return upon reconstitution.
Perishable biologics preserved using the HeMeDri™ technology are stable at cold or ambient temperatures, allowing wider distribution of temperature-sensitive biologics with minimal cold chain management.
Partial List of Biologicsthat have been exposed and tested using HeMemics HeMeDri™ Desiccation Technology
Blood Components
- Serum
- Plasma
- Cryo Precipitate
- Red Blood Cells
- Blood Platelets
Nucleated Cells
- HEK293
- CHO Cells
- Stem Cells
- Endothelial Cells
- B Cells
Contact us for product demonstration or discussion of process development
|
|
|
|
HBI is offering the following products and services:
Desiccated cells available for research and evaluation purposes
- Desiccated red blood cells for research
- Desiccated red blood cells for standards and quality control
Product and Process development using HeMeDri™ technology platform to stabilize temperature sensitive biologics
- Needs analysis
- Specification development
- Customized products and processes to stabilize temperature sensitive products for transportation and distribution
- Process optimization
|
|
